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Background: Cardiac function and myocardial strain are affected by cardiac afterload, which is in part due to the
stiffness of the aortic wall. In this study, we hypothesize that aortic pulse wave velocity (PWV) as a marker of aortic
stiffness correlates with conventional clinical and biochemical markers of cardiac function and perioperative
myocardial strain in aortic valve replacement (AVR).
Methods: Patients undergoing AVR for aortic stenosis between June 2010 and August 2012 were recruited for
inclusion in this study. PWV, NYHA class and left ventricular (LV) function were assessed pre-operatively. PWV was
analysed both as a continuous and dichotomous variable according to age-standardized reference values. B-type
natriuretic peptide (BNP) was measured pre-operatively, and at 3 h and 18-24 h after cardiopulmonary bypass (CPB).
NYHA class, leg edema, and LV function were recorded at follow-up (409 ± 159 days).
Results: Fifty-six patients (16 females) with a mean age of 71 ± 8.4 years were included, with 50 (89%) patients
completing follow-up. The NYHA class of PWV-norm patients was significantly lower than PWV-high patients both
pre- and post-operatively. Multiple logistic regression also highlighted PWV-cut off as an independent predictor of
NYHA class pre- and post-operatively (OR 8.3, 95%CI [2.27,33.33] and OR 14.44, 95%CI [1.49,139.31] respectively). No
significant relationship was observed between PWV and either LV function or plasma BNP.
Conclusion: In patients undergoing AVR for aortic stenosis, PWV is independently related to pre- and post-operative
NYHA class but not to LV function or BNP. These findings provisionally support the use of perioperative PWV as a
non-invasive marker of clinical functional status, which when used in conjunction with biomarkers of myocardial strain
such as BNP, may provide a holistic functional assessment of patients undergoing aortic valve surgery. However, in
order for PWV assessment to be translated into clinical practice and utilised as more than simply a research tool, further
validation is required in the form of larger prospective studies specifically designed to assess the relationship between
PWV and these functional clinical outcomes.
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In a normal, healthy, elastic aorta, radial expansion
during systole acts as a volume and pressure reservoir
(“cushioning effect”). This is possible because the aorta,
particularly proximally, is richer in elastin than the rest
of the arterial tree [1-3]. This property is of particular
importance for coronary perfusion after aortic valve
closure. When the elastic properties diminish, the aorta
becomes stiffer, and the change in aortic diameter during
systole and diastole is reduced. The rigidity of the aorta
increases pulse wave speed, causing the reflected pres-
sure wave towards the heart to occur at the beginning
of systole, rather than during diastole. Consequently,
increased systolic blood pressure and elevated cardiac
afterload results in left ventricular (LV) hypertrophy.
Furthermore, the absence of diastolic augmentation
reduces coronary flow during diastole and widens the
pulse pressure (PP) [1,4].
Aortic stiffness increases with age [3,5], and aortic PWV
is specifically associated with an increased risk of cardiovas-
cular events in the general population [6]. Meta-analysis
of 17 longitudinal studies including 15,877 participants re-
vealed that an increase of aortic PWV of 1 m/s increases
total CV events, CV mortality, and all-cause mortality
by 14%, 15%, and 15%, respectively [7]. In 2010, the
Reference Values for Arterial Stiffness’ Collaboration
published reference and normal values for PWV [8].
“Normal” values were derived from a population with
no cardiovascular risk factors (other than age and sex),
while “reference” values were derived from a population
with various risk factors, according to age and blood pres-
sure. The availability of such normal and reference values
for PWV per age group makes identifying individuals with
abnormal PWV possible and practical without the need
for recruiting matched control groups as long as the
methodology of measuring aortic PWV remains the
same. Among many indices of measuring aortic stiff-
ness, PWV is the gold standard parameter of arterial
stiffness as it is the most accepted, valid, reproducible,
and widely used [1,2,8]. As such, it is the method rec-
ommended by the European Network for Non-invasive
Investigation of Large Arteries for direct measure of
arterial stiffness [2].
Cardiac function assessment includes appraisal of clin-
ical, echocardiography and biochemical parameters. The
use of cardiac or myocardial biomarkers is essential for
assessing and monitoring cardiovascular diseases and for
predicting outcomes. Biomarkers of myocardial damage,
such as troponins, are different from biomarkers of myo-
cardial strain, such as natriuretic peptides. Natriuretic
peptides (NPs) are released from the heart in response
to pressure and volume overload to induce vasodilation,
natriuresis, and diuresis. In AS populations, NPs are re-
lated to the severity and/or functional status symptomsof AS disease, and increase progressively with worsening
NYHA functional class [9]. In patients who undergo valve
replacement, NP levels may potentially predict survival
and post-operative LV function [10,11].
Pulse wave velocity (PWV) is known to be significantly
associated with plasma BNP level in both healthy [12]
and hypertensive patients [13]. Indeed, in their study of
coronary artery disease patients, Sakuragi et al. propose
that increased PWV may in fact directly result in a rise
in BNP [14]. Aortic PWV has also been found to be
independently associated with LV ejection fraction (EF)
in patients with type 1 diabetes mellitus [15], and to be
inversely correlated with LV function in coronary artery
disease [16]. However, despite these findings, no study
currently addresses the relationship between aortic stiffness
and BNP in aortic valve replacement (AVR) patients,
and the association between aortic stiffness, cardiac
function and clinical outcomes after aortic valve surgery
remains to be assessed.
We hypothesize that aortic stiffness is related to cardiac
function and perioperative myocardial strain in patients
undergoing aortic valve replacement. As such, this study
aims to assess the relationship between aortic PWV and:
(a) pre- and post- operative cardiac function assessed by
NHYA class and echocardiography; (b) pre- and post- op-
erative BNP as a marker of myocardial strain; (c) the need
for post-operative inotropes; and (d) the development of
post-operative arrhythmia.
Methods
Overview
Ethical approval (11/H0709/3, North London Research
Ethic Committee 3) and participant informed consent
were obtained prior to undertaking this study. Patients
undergoing AVR for moderate to severe AS were eli-
gible. Patients were excluded if they had a history of or
presented with: (i) aortic dissection; (ii) thoracic aortic
(more than just the root) or abdominal aortic aneurysm;
(iii) Marfan’s syndrome; or (iv) chronic kidney disease.
All patient recruitment and data collection was performed
prospectively.
Aortic PWV, NYHA class, LV function, and plasma BNP
were assessed pre-operatively. BNP level was re-measured
3 h post-CPB and on day one (18–24 h post-CPB) after
AVR. Post-operative inotrope requirement for more
than 6 hours and any cardiac arrhythmia were also re-
corded. NYHA class, LV function, and the presence of
leg edema were recorded at the study-specific follow-up
visit (409 ± 159 days) post-operatively.
PWV was analyzed as a continuous variable using
traditional methods. In addition, PWV was analyzed as
a dichotomous variable (PWV-norm group vs. PWV-high
group) by categorizing patients according to the published
European normal values of PWV for the matched age
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divided into two groups:
A-PWV-norm group: PWV equal or below normal
reference values for their age group.
B- PWV-high group: PWV above the normal reference
values for their age group.
Pulse wave velocity measurement protocol
Prior to measurement all participants abstained from
tobacco, alcohol, tea or coffee for at least 2 hours. Patients
were rested for 10 minutes in a quiet, temperature-
controlled room (22-25°C) before the hemodynamic
measurements were taken. Brachial blood pressure
(BP) and heart rate were measured using a digital sphygmo-
manometer (Criticare, Model 506 N3, Waukesha, USA).
BP measurements were taken before and after PWV as-
sessment and the mean used for analysis. Aortic PWV
(carotid-femoral PWV) was measured with an automatic
applanation tonometry system (SphygmoCor Vx, AtCor
Medical, Australia). Briefly, with the patient resting in a
supine position, ECG-gated pulse waveforms were obtained
sequentially from the common carotid and then femoral ar-
teries. Propagation time of the pulse wave was measured
from the foot of the carotid waveform to that of the femoral
waveform referenced to the R wave on the recorded ECG.
The transit distance (mm) was measured over the body sur-
face by subtracting the supra-sternal notch to carotid site
distance from the supra-sternal notch to femoral site dis-
tance. PWV was subsequently calculated in m/s using the
Sphygmocor device by dividing the travelled distance by
the propagation time. Three to five readings were obtained
per patient and PWV was determined by averaging the
measurements meeting quality control parameters outlined
by SphygmoCor.
Clinical assessment
Clinical history and examination including NYHA func-
tional classification and the presence of leg oedema were
recorded both pre-operatively and at follow-up.
Echocardiography assessment
Cardiac function was determined according to the LV
functional class derived from pre-and post-operative
echocardiography. LV function was classified into good
(LV EF >50%), moderate (LV EF 31%–50%), poor (LV EF
21%–30%), and very poor (LV EF equal or ≤20%) [17].
Biochemical assessment of B-type natriuretic peptide (BNP)
Myocardial strain was assessed by measuring BNP pre-
operatively, 3 h post-CPB, and on day one (18–24 h post-
CPB) after AVR. Venous blood samples were collected in
Ethylenediaminetetraacetic acid (EDTA)-containing tubes
and immediately centrifuged to separate plasma. BNP wasmeasured using a chemiluminescent immunoassay
(Biosite Triage, Biosite Incorporated, San Diego, CA,
USA, currently called Alere Triage MeterPro, Alere Ltd,
Stockport, UK), for which the accuracy, analytic sensitivity,
and stability characteristics have been previously vali-
dated and described [18,19]. All BNP measurements were
performed within 30 minutes of sample collection by a
single operator (EK).
Statistical analysis
Statistical analysis was conducted using IBM SPSS statistics
20.0 (IBM Corp., Armonk, NY, USA). Patient characteristics
and results are expressed as means ± standard deviation for
continuous variables and as frequencies for categorical
variables. P-values < 0.05 were considered statistically
significant. Test for normality was carried out on all var-
iables, and non-normally distributed variables trans-
formed for the purpose of regression analysis. PWV was
analyzed both as a continuous and dichotomous vari-
able (PWV cut-off ). Inter-group comparison was carried
out using an independent samples t-test or non-parametric
equivalent (Mann–Whitney U test) for continuous vari-
ables, and Pearson Chi-square or Fisher’s exact test for
categorical variables. The association between any two
variables was tested with bivariate correlation analysis
using Spearman's rank-order correlation (both continuous),
point biserial correlation (continuous vs. dichotomous),
Phi test (both dichotomous variables), or Carmer V
(both nominal other than 2 × 2). All variables with sig-
nificant correlation, in addition to age and gender,
were then included in two models of multiple regres-
sion, linear or logistic based on the dependent variable
(enter method): (1) Model 1: including PWV as a con-
tinuous predictor; and (2) Model 2: including PWV
cut-off as a dichotomous predictor.
Results
Descriptive results
Between June 2010 and August 2012, 56 patients (16
females) with a mean (±SD) age of 71 ± 8.4 years were
included in this study. Fifty (89%) patients attended
follow-up, however the remaining 6 refused to return
after their initial enrollment at the pre-operative stage.
No mortality or cerebrovascular events were recorded
during the follow-up period. Thirty-five (62.5%) pa-
tients had PWV measurements equal or below the ref-
erence value for their age group (PWV-norm group),
and 21 patients (37.5%) had PWV measurements above
the reference value for their age group (PWV-high group).
There was no significant difference between the PWV-
norm and PWV-high groups in terms of age, gender,
severity of pre-operative aortic stenosis, classical
hemodynamic measurements or other clinical charac-
teristics (Table 1).
Table 1 Demographic and clinical characteristics
Parameter Total PWV-norm PWV-high P-value
n = 56 n = 35 n = 21
Male 40 (71.4%) 27 (77.1%) 13 (61.9%) 0.36
Age (years) 71 ± 8.4 70.2 ± 9 72 ± 8 0.43
Age range (years) 53 - 90 53 - 90 56 - 85
White Caucasian [n (%)] 55 (98%) 35 (100%) 20 (95%) 0.37
BMI (kg/m2) 27.2 (4.2) 26.5 (4.3) 28.1 (4.1) 0.18
SBP (mmHg) 136 ± 24 132 ± 27 142 ± 18 0.14
DBP (mmHg) 76 ± 11 75 ± 12 77 ± 11 0.58
MAP (mmHg) 97 ± 12 96 ± 13 98 ± 11 0.56
DM [n (%)] 8 (14.3%) 4 (11.4%) 4 (19.1%) 0.43
Smoking [n (%)] 2 (3.6%) 2 (5.7%) 0 (0%) 0.21
Cholesterol (mmol/l) 4.5 ± 1.2 4.6 ± 1.3 4.4 ± 0.8 0.60
Hypertension [n (%)] 38 (67.9%) 22 (62.9%) 16 (76.2%) 0.38
PVD [n (%)] 2 (3.6%) 0 (0%) 2 (9.5%) 0.13
EuroSCORE (Logistic) 5.5 ± 4.3 5.1 ± 4 6.1 ± 4.7 0.23
Concomitant CABG 15 (26.8%) 10 (28.5%) 5 (23.8%) 0.76
CPB time (minutes) 87 ± 23 87 ± 20 87 ± 27 0.95
Hospital stay (days) 6.7 ± 1.7 6.6 ± 1.6 6.7 ± 1.8 0.84
PWV (m/s) 9.3 ± 2.2 8.1 ± 1.5 11.3 ± 1.6 <0.001
Values are shown as n (%) for categorical variables and the mean ± standard
deviation for continuous variables. bold values indicate statistically significant
values. Abbreviations: DM diabetes mellitus, BMI body mass index, SBP systolic
blood pressure, DBP diastolic blood pressure, PP pulse pressure, MAP, mean
arterial blood pressure, PVD peripheral vascular disease, CABG coronary artery
bypass graft surgery, CPB cardiopulmonary bypass, PWV pulse wave velocity.
Table 2 Cardiac assessment characteristics
Parameter Total PWV-norm PWV-high P-value
n = 56 n = 35 n = 21
Pre-operative
Aortic valve area (cm2) 0.73 ± 0.2 0.74 ± 0.2 0.71 ± 0.2 0.67
AVMG (mmHg) 48 ± 13 50 ± 13 46 ± 11 0.27
AVPG (mmHg) 82 ± 24 86 ± 27 76 ± 19 0.13
Ejection fraction 59 ± 15 58 ± 15 61 ± 16 0.56
LVDDiam (cm) 4.79 ± 0.72 4.78 ± 0.75 4.82 ± 0.69 0.85
LVSDiam (cm) 3.34 ± 0.83 3.25 ± 0.76 3.47 ± 0.94 0.37
NYHA (n [%]) <0.01
Class I 16 (29%) 16 (46%) 0 (0%)
Class II 30 (53%) 15 (43%) 15 (71%)
Class III 10 (18%) 4 (11%) 6 (29%)
LV function (n [%]) 0.97
Good 41 (76%) 25 (76%) 16 (76%)
Moderate 10 (18%) 6 (18%) 4 (19%)
Poor 3 (6%) 3 (6%) 3 (5%)
BNP pg/ml 134 ± 183 88 ± 88 214 ± 264 0.09
Immediate post-operative
BNP pg/ml (3 h post-CPB) 112 ± 143 85 ± 81 158 ± 199 0.32
BNP pg/ml (18 h post-CPB) 334 ± 179 288 ± 157 406 ± 191 0.02
Inotropes (n [%]) 16 (29%) 8 (23%) 8 (40%) 0.22
Arrhythmia (n [%]) 23 (41%) 16 (46%) 7 (33%) 0.41
Post-operative
(409 ± 159 days)
n = 50
NYHA (n [%]) <0.001
Class I 40 (80%) 29 (97%) 11 (55%)
Class II 10 (20%) 1 (3%) 9 (45%)
LV function (n [%]) 1.0
Good 40 (87%) 23 (85%) 17 (89%)
Moderate 6 (13%) 4 (15%) 2 (10%)
Leg edema (n [%]) 7 (14%) 1 (3%) 6 (30%) 0.01
Values are shown as n (%) for categorical variables and means ± standard
deviation for continuous variables. bold values indicate statistically significant
values. Abbreviations: AVMG aortic valve mean gradient, AVPG aortic valve peak
gradient, LVDDiam left ventricular diastolic diameter, LVSDiam left ventricular
systolic diameter, NYHA New York Heart Association, LV left ventricle, BNP
B-type natriuretic peptide.
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There was a significant difference in NYHA class between
the two groups in favor of PWV-norm pre- and post-
operatively (Table 2). Pre-operatively, 0% of the PWV-high
group was categorized as NYHA class I compared to 46%
of the PWV-norm group, while the percentage of patients
in NYHA classes II & III was much higher in the PWV-
high group. Post-operatively there was an overall improve-
ment in NYHA status in both groups, with no patients
categorized as NYHA class III after surgery. The number
of patients classified as NYHA class II fell from 43% to 3%
in the PWV-norm group and from 71% to 45% in the
PWV-high group (Table 2).
Bivariate correlation demonstrated a significant associ-
ation between NYHA class and PWV, particularly where
PWV was measured as a dichotomous variable (Table 3).
Chi-square analysis was used to identify any association
between PWV groups (PWV cut-off ) and NYHA class.
There was a statistically significant association between
PWV cut-off and NYHA pre- (X2 = 13.76, P < 0.01) and
post- operatively (X2 = 13.02, P < 0.001). Multiple logistic
regression adjusted for age, gender, and other significantly
correlated variables (Table 4), confirmed these findings and
that PWV (continuous variable) was an independent
predictor of pre-operative NYHA class (OR 1.43, 95%CI [1.08–1.91], but not of post-operative NYHA. PWV
cut-off (dichotomous) was a stronger predictor of NYHA
class than PWV-norm (continuous). Patients in the PWV-
high group were 8.3 times more likely to be in a higher
NYHA class pre-operatively and 14.4 times more likely
to be in a higher NYHA class post-operatively than
PWV-norm patients (Table 4).
Pulse wave velocity and left ventricular (LV) function
There was no significant difference in categorical group-
ings of LV function (good, moderate, and poor) between
Table 3 Bivariate correlation between potential predictors, cardiac function and myocardial strain parameters
Age Gender (male) DM Hypertension MAP AVMG (pre–op) CPB time PWV value PWV cut–off
Pre–operative
LV function 0.18 −0.19 −0.11 −0.38** −0.26 −0.13 −0.04 −0.12 −0.03
NYHA class 0.09 −0.05 0.18 −0.11 0.04 −0.14 −0.08 0.36** 0.50**
BNP 0.27 −0.35* −0.19 −0.07 −0.30* 0.10 −0.00 0.21 0.34*
Immediate post-operative
BNP (3 h post-CPB) 0.22 −0.34* −0.23 −0.13 −0.20 −0.14 −0.15 0.09 0.26
BNP (18 h post-CPB) 0.24 −0.26 −0.29* −0.01 0.03 −0.09 −0.04 0.24 0.32*
Inotropes 0.24 −0.24 −0.11 −0.15 −0.06 −0.08 −0.14 0.35* 0.18
Arrhythmia 0.24 0.13 −0.14 0.11 −0.20 0.04 −0.07 0.06 −0.12
Post–operative
LV function 0.07 0.10 0.23 −0.12 −0.11 −0.1 −0.08 −0.14 −0.06
NYHA class 0.03 −0.24 0.28* 0.15 −0.12 −0.15 0.15 0.20 0.51**
Leg edema −0.02 −0.13 0.02 0.05 0.08 −0.21 0.03 0.07 0.38**
Values are shown as correlation coefficients (r); bold values indicate statistically significant values; *Correlation is significant at the 0.05 level (2-tailed); **Correlation
is significant at the 0.01 level (2-tailed). Abbreviations: DM diabetes mellitus, MAP mean arterial blood pressure, AVMG aortic valve mean gradient, CPB
cardiopulmonary bypass, PWV pulse wave velocity, LV left ventricle, NYHA New York Heart Association Functional Classification, BNP B-type Natriuretic peptides.
Table 4 Multiple logistic regression (binary and ordinal) to identify predictors of cardiac function and myocardial strain
Predictors Pre-operative Post-operative
OR (95% CI) OR (95% CI)
LV function NYHA class Inotropes Arrhythmia LV function NYHA class Leg edema
Model 1
PWV value 0.73 1.43* 1.33 0.94 0.76 1.20 1.09
(0.52–1.05) (1.08–1.91) (0.94–1.88) (0.71–1.26) (0.46–1.23) (0.76–1.91) (0.71–1.67)
Age 1.11* 0.97 1.03 1.07 1.05 0.93 0.97
(1.01–1.23) (0.91–1.04) (0.94–1.12) (0.99–1.16) (0.93–1.19) (0.81–1.07) (0.86–1.09)
Gender (male) 0.35 1.11 0.36 1.80 1.80 0.34 0.47
(0.08–1.49) (0.35–3.57) (0.09–1.45) (0.49–6.56) (0.18–18.01) (0.04–2.36) (0.08–2.66)
DM 5.01
(0.72–34.51)
Hypertension 0.20*
(0.05–0.81)
Model 2
PWV cut-off 0.91 8.3** 1.78 0.55 0.81 14.44* 11.77*
(PWV-high) (0.21–3.84) (2.27–33.33) (0.49–6.43) (0.16–1.84) (0.12–5.41) (1.49–139.31) (1.26–109.77)
Age 1.06 1.02 1.06 1.07* 1.03 0.97 0.97
(0.98–1.15) (0.95–1.08) (098–1.15) (1.0–1.15) (0.91–1.15) (0.84–1.10) (0.86–1.09)
Gender (male) 0.47 1.21 0.34 1.65 2.10 0.43 0.62
(0.11–1.92) (0.38–4.0) (0.08–1.30) (0.45–6.03) (0.19–22.13) (0.05–3.52) (0.09–4.18)
DM 4.45
(0.47–41.66)
Hypertension 0.18*
(0.04–0.71)
Values are shown as odd ratio (95% CI), bold values indicate statistically significant values; *is significant at the 0.05 level (2-tailed); **is significant at the 0.01 level
(2-tailed); Model 1 includes PWV value as a continuous predictor; Model 2 includes PWV cut-off as a dichotomous predictor. Abbreviations: LV left ventricle, NYHA
New York Heart Association (NYHA) Functional Classification, PWV pulse wave velocity, DM diabetes mellitus.
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Table 5 Multiple linear regression to identify predictors
of the myocardial strain biomarker BNP
Predictors BNP
(pre-op.)A
BNP
(3 h post-CPB)A
BNP
(18 h post-CPB)A
Model 1
PWV value 0.06 0.11 0.18
(0.72) (0.51) (0.29)
Age 0.26 0.29 0.01
(0.11) (0.09) (0.95)
Gender (male) −0.20 −0.38 −0.12
(0.15) (0.0.1) (0.43)
MAP −0.36
(0.01)
DM −0.30
(0.05)
Model 2
PWV cut-off 0.20 0.09 0.32
(PWV-high) (0.14) (0.51) (0.03)
Age 0.27 0.21 0.06
(0.05) (0.14) (0.65)
Gender (male) −0.17 −0.34 −0.09
(0.22) (0.02) (0.51)
MAP −0.35
(0.01)
DM −0.33
(0.03)
Values are shown as beta (P-value), bold values indicate statistical significance;
ALog transformation. Model 1 includes PWV value as a continuous predictor;
Model 2 includes PWV cut-off as a dichotomous predictor. Abbreviations: DM
diabetes mellitus, MAP mean arterial blood pressure, PWV pulse wave
velocity, BNP B-type natriuretic peptides.
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(Table 2). Although the overall improvement in LV
function post-operatively did not reach statistical sig-
nificance (P = 0.058), no patients were categorized as
‘poor’ LV function post-operatively. Further correlation
and multiple logistic regression (Tables 3 and 4) analyses
confirm the absence of any relationship between PWV
and LV function, whilst also demonstrating a significant
correlation between pre-operative LV function and both
age and hypertension (OR 1.11, 95% CI [1.01–1.23] and
0.20 [0.05–0.81] respectively).
Pulse wave velocity and myocardial strain
Plasma BNP (pg/ml) was similar between PWV-norm and
PWV-high groups pre-operatively and at 3 h post-CPB,
however it was significantly higher in the PWV-high group
at 18 h after CPB (288 ± 157 vs. 406 ± 191, P =0.02; Table 2).
PWV as a dichotomous variable (PWV-cut-off) was signifi-
cantly associated with both pre-operative BNP (r = 0.34)
and BNP at 18 h post-CPB (r = 0.32). However, this was not
seen when PWV was analysed as a continuous variable.
Multiple regression analysis (Table 5) demonstrates that
age and mean atrial pressure (MAP) were independently
related to BNP pre-operatively, and gender independently
related to BNP at 3 h post-CPB. PWV cut-off and diabetes
were the only two variables independently related to BNP
at 18 h after CPB.
Clinical findings
Leg edema was present in 14% (n = 7) cases at follow-up,
85% of which were in the PWV-high group (P = 0.01).
Bivariate and multiple logistic regression (Tables 3 and 4)
revealed a significant relationship between PWV cut-off
and post-operative leg edema (r = 0.38, OR 11.77, 95% CI
[1.26–109.77]). Patients in the PWV-high group required
more post-operative inotropes (>6 hours) (40% vs. 23%),
and developed less arrhythmia than the PWV-norm group
(33% vs. 46%) although neither outcome reached statistical
significance (Table 2). PWV as a continuous variable sig-
nificantly correlated with the need for inotropes beyond
6 hours post-operatively (r = 0.35; Table 3), however,
this association disappeared in multiple logistic regres-
sion (OR 1.33 95%CI [0.94–1.88]; Table 4).
Discussion
This is the first study of its kind to address the relationship
between aortic PWV and NYHA class in surgical patients.
The predictive value of NYHA for survival, quality of life,
and other outcomes has been reported extensively [20-22].
However, NYHA may be limited by the poor correlation of
patient reports with cardiopulmonary exercise testing, and
significant inconsistencies have been noted between classi-
fications made by different observers (physicians), particu-
larly in classes II and III [23]. As such, a non-invasivequantitative measure that correlates strongly with NYHA
classification is of great clinical interest, with the potential
to provide a more robust and reproducible predictor of
morbidity, mortality and quality of life outcomes.
The results of this study demonstrate a significant
improvement in NYHA functional class following AVR,
supporting the findings of previous studies [24]. A sig-
nificant correlation between NYHA class and PWV was
also observed in AS patients both pre- and post- AVR,
again consistent with findings of other studies examin-
ing this relationship in heart failure and ischaemic heart
disease [25,26]. In addition, when examining clinical
markers of cardiac function, PWV cut-off predicted the
likelihood of developing post-operative leg edema des-
pite good LV function.
Controversially, we observed no significant relationship
between PWV and LV function as assessed by echocardi-
ography. It is possible that this finding reflects the differ-
ence between LV ejection fraction as a specific measure of
Kidher et al. Journal of Cardiothoracic Surgery 2014, 9:102 Page 7 of 8
http://www.cardiothoracicsurgery.org/content/9/1/102cardiac function and less-specific clinical assessments
such as NYHA class, which may be influenced by non-
cardiac factors. However, it is also possible that although
LV function is commonly employed in clinical studies, its
use to reflect global cardiac function may be inappropriate
as it fails to distinguish patients with predominantly dia-
stolic heart failure in whom LV function may be normal
[27]. Regrettably, we did not assess diastolic dysfunction pa-
rameters in our study, which if included may have aligned
the relationship between PWV and echocardiographic
assessment with that of clinical assessment (NYHA). In
addition, as over 75% of our patients were categorized
as “good” LV function both pre- and post-operatively,
the low numbers of patients with impaired LV function
may have led to our study being underpowered to estab-
lish any significance between PWV and this outcome.
Consistent with the absence of correlation between
PWV and LV function in our sample, we did not identify
any significant association between PWV as a continu-
ous variable and BNP as a marker of myocardial strain.
This finding appears to be contradictory to the positive
correlation that has been observed in an otherwise healthy
population and in patients with both diabetes and cor-
onary artery disease [12-14]. However, when examining
PWV as a dichotomous variable (PWV-cut-off) a positive
correlation similar to that previously reported is observed
both pre-operatively and at 18 hours post-CPB. It is there-
fore possible that due to its small sample size, our study
is underpowered to detect significant correlation when
PWV is expressed as a continuous variable. Alternatively
however, the pathology of aortic valve stenosis may con-
found and attenuate the effect of aortic stiffness on LV
function and BNP release. As such, this finding requires
ongoing research with increased sample size to definitively
answer this question.
Limitations
The results presented here should be considered in the
context of a number of limitations. Firstly, as previously
mentioned, the use of LV ejection fraction as a marker
of cardiac function may have led to the inappropriate
classification of patients with diastolic dysfunction in the
‘good’ cardiac function group. Second, the relatively small
sample size of our study may have left it underpowered to
detect significance for relationships such as that between
PWV and LV function. Third, despite the significant
relationship between PWV cut-off and post-operative
leg oedema (r = 0.38, OR 11.77, 95% CI [1.26–109.77]),
leg oedema is a subjective measure with the potential
to be influenced by several potential confounders aris-
ing during the perioperative period. Furthermore, the
exact mechanism of this relationship is unknown, and
further research is therefore required to evaluate this
association in more detail.Finally, we did not evaluate other biological factors
such as tumor necrosis factor alpha, high sensitivity
C-reactive protein, plasminogen activator inhibitor-1,
and elastin-derived peptide, which may have provided
an explanation for the observed difference in PWV in
the otherwise demographically similar population studied
here. In addition, future larger studies should also examine
the role of potential confounders not assessed here that
may affect the relationship between PWV, cardiac function
and myocardial strain. These include the degree of aortic
atherosclerosis, aortic calcification, type and duration
of pharmacotherapy.
Conclusions
Aortic stiffness measured by aortic PWV is independently
associated with pre- and post-operative NYHA and leg
edema after aortic valve replacement, but not to LV func-
tion or BNP. These findings provisionally support the use
of perioperative PWV as a non-invasive marker of clinical
functional status, which when used in conjunction with
biomarkers of myocardial strain such as BNP, may provide
a holistic functional assessment of patients undergoing
aortic valve surgery. However, in order for PWV assess-
ment to be translated into clinical practice and utilised as
more than simply a research tool, further validation is re-
quired in the form of larger prospective studies specifically
designed to assess the relationship between PWV and these
functional clinical outcomes.
The preliminary data provided in this study may now be
used to develop larger multicenter projects evaluating the
role of arterial stiffness and neurohormonal predictors in
the assessment of cardiac surgical patients. Furthermore,
as a quantitative but non-invasive marker of functional sta-
tus, PWV may help to improve the power of operative risk
prediction models thus optimizing perioperative assessment
and subsequently improving surgical outcomes.
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